Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jeevan Scientific Technology has a quick ratio of 2.35. It generally indicates good short-term financial strength.
The historical rank and industry rank for Jeevan Scientific Technology's Quick Ratio or its related term are showing as below:
BOM:538837'
s Quick Ratio Range Over the Past 10 Years
Min: 0.76 Med: 1.86 Max: 2.56
Current: 2.35
During the past 13 years, Jeevan Scientific Technology's highest Quick Ratio was 2.56. The lowest was 0.76. And the median was 1.86.
BOM:538837's Quick Ratio is ranked worse than 61.37% of 1411
companies
in the Biotechnology industry
Industry Median: 3.59
vs BOM:538837: 2.35
Jeevan Scientific Technology (BOM:538837) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Jeevan Scientific Technology Quick Ratio Related Terms
Jeevan Scientific Technology Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:538837 vs VRTX, REGN, ALNY: Quick Ratio Comparison
For the Biotechnology subindustry, Jeevan Scientific Technology's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jeevan Scientific Technology Quick Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Jeevan Scientific Technology's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Jeevan Scientific Technology's Quick Ratio falls into.
Jeevan Scientific Technology Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jeevan Scientific Technology (BOM:538837) has a Quick Ratio of 2.35 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Jeevan Scientific Technology and its competitors. This is 26% above median its historical median of 1.86. Over the past decade, Jeevan Scientific Technology's Quick Ratio has ranged from 0.76 to 2.56. According to the industry distribution chart, Jeevan Scientific Technology ranks #866 out of 1411 companies in the Biotechnology industry, placing it in the top 61.4%.
Is Jeevan Scientific Technology's Quick Ratio too high?
Jeevan Scientific Technology's current Quick Ratio of 2.35 is 26% above median its 10-year median of 1.86. Over the past 10 years, this metric has ranged from a low of 0.76 to a high of 2.56. The Biotechnology industry median Quick Ratio is 3.59. Jeevan Scientific Technology's value of 2.35 is 34.5% below this industry median. Based on the distribution chart, Jeevan Scientific Technology ranks #866 out of 1411 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Jeevan Scientific Technology has a GF Score™ of 65/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jeevan Scientific Technology's Quick Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Jeevan Scientific Technology ranks #866 out of 1411 companies for Quick Ratio. This places Jeevan Scientific Technology in the lower half of its industry. The industry median Quick Ratio is 3.59. Jeevan Scientific Technology's value of 2.35 is 34.5% below this benchmark. Historically, Jeevan Scientific Technology's own Quick Ratio has ranged from 0.76 to 2.56 over the past decade. While the company's 10-year median is 1.86 vs. the industry median of 3.59, Jeevan Scientific Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Biotechnology company?
The median Quick Ratio among Biotechnology companies is 3.59, based on 1,411 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jeevan Scientific Technology's current Quick Ratio of 2.35 is 34.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Jeevan Scientific Technology and its competitors. For the Biotechnology industry, the median Quick Ratio is 3.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jeevan Scientific Technology's current Quick Ratio is 2.35, which is 26% above median its own 10-year median of 1.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jeevan Scientific Technology stock overvalued right now?
Based on GuruFocus' analysis, Jeevan Scientific Technology (BOM:538837) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹61.75, compared to a current price of ₹72.77 — trading 17.8% above its estimated fair value. The current Quick Ratio is 2.35, which is 26% above median its 10-year median of 1.86 and 34.5% below the Biotechnology industry median of 3.59. Jeevan Scientific Technology's overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Jeevan Scientific Technology (BOM:538837), the current Quick Ratio is 2.35 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jeevan Scientific Technology (BOM:538837) Overvalued in 2026?
Based on GuruFocus' analysis, Jeevan Scientific Technology stock appears to be overvalued.
The current stock price of ₹72.77 is trading 17.8% above its estimated GF Value™ of ₹61.75.
GuruFocus considers Jeevan Scientific Technology to be Modestly Overvalued.
Key valuation signals for BOM:538837:
Quick Ratio: 2.35 (26% above median its 10-year median of 1.86)
GF Value™: ₹61.75 vs. price of ₹72.77 (17.8% above fair value)
Industry Position: 34.5% below the Biotechnology median (#866 of 1411)
No single metric tells the full story. See the BOM:538837 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jeevan Scientific Technology Ltd is an India-based company engaged in providing clinical research and data management services. Jeevan Scientific is an independent clinical contract research organization, offering reliable, cost-effective, and technology-driven clinical research solutions to various clients across the globe. Its services offer high-value testing services, including bioanalytical services for small and large molecules, ranging across generics, biosimilars, and other new drugs. It operates in a single segment, namely clinical research services.
65GF Score
Get the complete analysis for BOM:538837
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:538837 has been successfully added to your 
